| Dr Jason Shuang Hua, DO | |
|
1333 Moursund St, Houston, TX 77030-3405 | |
| (713) 797-5929 | |
| (713) 799-6997 |
| Full Name | Dr Jason Shuang Hua |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 8 Years |
| Location | 1333 Moursund St, Houston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063960375 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | S5930 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Houston Methodist Hospital | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tmh Physician Associates Pllc | 4486711744 | 1557 |
News Archive
A new study has found that men have positive attitudes towards an innovative male contraceptive, Vasalgel. The landmark study, published in Cogent Medicine, is the first insight into how men perceive the new contraceptive and gives promising signs that Vasalgel may revolutionise approaches to reproductive health.
Obesity raises the prevalence of high blood pressure among adolescents but the increase is particularly pronounced among Hispanics compared to white, African-American or Asian ethnic groups, according to a study by researchers at McGovern Medical School at The University of Texas Health Science Center at Houston. Results were published in the journal Pediatrics.
The latest study on hormone therapy and Alzheimer's disease shows no relationship between taking the drugs and whether you may develop the disease years later.
A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use. Findings suggest that systematic screening of intravenous (IV) drug users who are new to the prison system could identify more than 7,000 cases of HCV across the U.S. annually—even among asymptomatic inmates.
Ambrx and Zhejiang Medicine Co. Ltd. today announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally developed site-specific antibody drug conjugate targeting Her2-positive breast cancer.
› Verified 2 days ago
| Entity Name | Ut Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033157821 PECOS PAC ID: 8426960360 Enrollment ID: O20031107000268 |
News Archive
A new study has found that men have positive attitudes towards an innovative male contraceptive, Vasalgel. The landmark study, published in Cogent Medicine, is the first insight into how men perceive the new contraceptive and gives promising signs that Vasalgel may revolutionise approaches to reproductive health.
Obesity raises the prevalence of high blood pressure among adolescents but the increase is particularly pronounced among Hispanics compared to white, African-American or Asian ethnic groups, according to a study by researchers at McGovern Medical School at The University of Texas Health Science Center at Houston. Results were published in the journal Pediatrics.
The latest study on hormone therapy and Alzheimer's disease shows no relationship between taking the drugs and whether you may develop the disease years later.
A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use. Findings suggest that systematic screening of intravenous (IV) drug users who are new to the prison system could identify more than 7,000 cases of HCV across the U.S. annually—even among asymptomatic inmates.
Ambrx and Zhejiang Medicine Co. Ltd. today announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally developed site-specific antibody drug conjugate targeting Her2-positive breast cancer.
› Verified 2 days ago
| Entity Name | Tmh Physician Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275779225 PECOS PAC ID: 4486711744 Enrollment ID: O20090401000100 |
News Archive
A new study has found that men have positive attitudes towards an innovative male contraceptive, Vasalgel. The landmark study, published in Cogent Medicine, is the first insight into how men perceive the new contraceptive and gives promising signs that Vasalgel may revolutionise approaches to reproductive health.
Obesity raises the prevalence of high blood pressure among adolescents but the increase is particularly pronounced among Hispanics compared to white, African-American or Asian ethnic groups, according to a study by researchers at McGovern Medical School at The University of Texas Health Science Center at Houston. Results were published in the journal Pediatrics.
The latest study on hormone therapy and Alzheimer's disease shows no relationship between taking the drugs and whether you may develop the disease years later.
A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use. Findings suggest that systematic screening of intravenous (IV) drug users who are new to the prison system could identify more than 7,000 cases of HCV across the U.S. annually—even among asymptomatic inmates.
Ambrx and Zhejiang Medicine Co. Ltd. today announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally developed site-specific antibody drug conjugate targeting Her2-positive breast cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason Shuang Hua, DO 1333 Moursund St Ste 129, Houston, TX 77030-3405 Ph: (713) 797-5929 | Dr Jason Shuang Hua, DO 1333 Moursund St, Houston, TX 77030-3405 Ph: (713) 797-5929 |
News Archive
A new study has found that men have positive attitudes towards an innovative male contraceptive, Vasalgel. The landmark study, published in Cogent Medicine, is the first insight into how men perceive the new contraceptive and gives promising signs that Vasalgel may revolutionise approaches to reproductive health.
Obesity raises the prevalence of high blood pressure among adolescents but the increase is particularly pronounced among Hispanics compared to white, African-American or Asian ethnic groups, according to a study by researchers at McGovern Medical School at The University of Texas Health Science Center at Houston. Results were published in the journal Pediatrics.
The latest study on hormone therapy and Alzheimer's disease shows no relationship between taking the drugs and whether you may develop the disease years later.
A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use. Findings suggest that systematic screening of intravenous (IV) drug users who are new to the prison system could identify more than 7,000 cases of HCV across the U.S. annually—even among asymptomatic inmates.
Ambrx and Zhejiang Medicine Co. Ltd. today announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally developed site-specific antibody drug conjugate targeting Her2-positive breast cancer.
› Verified 2 days ago
Dr. Suzanne Marie Manzi, M.D., FAAPMR Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4126 Southwest Fwy Ste 1700, Houston, TX 77027 Phone: 346-217-1111 Fax: 346-571-2189 | |
Miguel Ernesto Velez, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2727 W Holcombe Blvd, Houston, TX 77025 Phone: 713-442-0000 | |
Sara Goel, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7700 Main St Ste 400, Houston, TX 77030 Phone: 346-230-4070 Fax: 281-605-6804 | |
Dr. Michael Krebs, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 5202 Redstart St, Houston, TX 77035 Phone: 281-531-5200 Fax: 281-531-5430 | |
Dr. Tova Liana Alladice, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8200 Wednesbury Ln, Suite 360, Houston, TX 77074 Phone: 713-484-6200 Fax: 713-773-0905 | |
Susan Victoria Kattula Gammon, OTR/L Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6621 Fannin St., Houston, TX 77030 Phone: 832-826-6121 Fax: 630-792-1801 | |
Savitha Bonthala, D.O., M.P.H. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1300 Binz St Fl 3, Houston, TX 77004 Phone: 713-285-1000 |